OLUMIANT® Long-Term Safety Profile Established Up to 9.3 Years in Integrated Analysis of More Than 3,700 Patients with Rheumatoid Arthritis
News Channel 10,
INDIANAPOLIS, Nov. 9, 2021 /PRNewswire/ -- OLUMIANT® (baricitinib) maintained a consistent safety profile in a long-term…